Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.
Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force.
Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460.
Unraveling Hurthle cell lesions of the thyroid using molecular findings.
Wong KS.
Cancer Cytopathol. 2022 Jun;130(6):405-406. doi: 10.1002/cncy.22567. Epub 2022 Mar 14.
Hurthle cell lesions of the thyroid: Progress made and challenges remaining.
Wong KS, Angell TE, Barletta JA, Krane JF.
Cancer Cytopathol. 2021 May;129(5):347-362. doi: 10.1002/cncy.22375. Epub 2020 Oct 27.
Hurthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis.
Coca-Pelaz A, Rodrigo JP, Shah JP, Sanabria A, Al Ghuzlan A, Silver CE, Shaha AR, Angelos P, Hartl DM, Mäkitie AA, Olsen KD, Owen RP, Randolph GW, Simó R, Tufano RP, Kowalski LP, Zafereo ME, Rinaldo A, Ferlito A.
Adv Ther. 2021 Oct;38(10):5144-5164. doi: 10.1007/s12325-021-01876-7. Epub 2021 Aug 22.
Genetics, Diagnosis, and Management of Hurthle Cell Thyroid Neoplasms.
McFadden DG, Sadow PM.
Front Endocrinol (Lausanne). 2021 Jun 10;12:696386. doi: 10.3389/fendo.2021.696386. eCollection 2021.
Granular cell tumor of thyroid: a case series with molecular characterization highlighting unique pitfalls.
Srivastava P, Da Cruz Paula A, Weigelt B, Pareja F, Reis-Filho JS, Yip L, Pantanowitz L, Seethala RR.
Endocrine. 2022 May;76(2):395-406. doi: 10.1007/s12020-022-03006-x. Epub 2022 Feb 17.
Hurthle cell tumor.
Chen HY, Benjamin LB, Chen MF.
Int Surg. 1996 Apr-Jun;81(2):168-70.
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update.
Bischoff LA, Ganly I, Fugazzola L, Buczek E, Faquin WC, Haugen BR, McIver B, McMullen CP, Newbold K, Rocke DJ, Russell MD, Ryder M, Sadow PM, Sherman E, Shindo M, Shonka DC Jr, Singer MC, Stack BC Jr, Wirth LJ, Wong RJ, Randolph GW.
JAMA Otolaryngol Head Neck Surg. 2024 Mar 1;150(3):265-272. doi: 10.1001/jamaoto.2023.4323.
Thyroid Hurthle cell tumors: research of potential markers of malignancy.
Donatini G, Beaulieu A, Castagnet M, Kraimps JL, Levillain P, Fromont G.
J Endocrinol Invest. 2016 Feb;39(2):153-8. doi: 10.1007/s40618-015-0356-x. Epub 2015 Jul 19.
Dysregulation of Parkin-mediated mitophagy in thyroid Hurthle cell tumors.
Lee J, Ham S, Lee MH, Kim SJ, Park JH, Lee SE, Chang JY, Joung KH, Kim TY, Kim JM, Sul HJ, Kweon GR, Jo YS, Kim KS, Shong YK, Gasparre G, Chung JK, Porcelli AM, Shong M.
Carcinogenesis. 2015 Nov;36(11):1407-18. doi: 10.1093/carcin/bgv122. Epub 2015 Sep 8.
